ainuovirine   Click here for help

GtoPdb Ligand ID: 13766

Synonyms: compound 10b [PMID: 20138513] | GS-9441 [3] | KM-023 | KM023
Approved drug PDB Ligand
ainuovirine is an approved drug
Compound class: Synthetic organic
Comment: Ainuovirine (KM-023) is a non-nucleoside reverse-transcriptase inhibitor (NNRTI) class antiretroviral that is intended to treat human immunodeficiency virus (HIV) type 1 infection [1-2].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 90.27
Molecular weight 325.36
XLogP 1.36
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCN1C(=C(C(C)C)C(=O)NC1=O)C(=O)C2=CC(=CC(=C2)C)C#N
Isomeric SMILES CCN1C(=C(C(=O)NC1=O)C(C)C)C(=O)C2=CC(=CC(=C2)C#N)C
InChI InChI=1S/C18H19N3O3/c1-5-21-15(14(10(2)3)17(23)20-18(21)24)16(22)13-7-11(4)6-12(8-13)9-19/h6-8,10H,5H2,1-4H3,(H,20,23,24)
InChI Key AYPIJAMXGVYYRQ-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
The Chinese drug regulator (NMPA) approved the triple combination of ainuovirine, lamivudine and tenofovir (ANV) as an HIV anti-retroviral therapy in September 2024.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05420246 Efficacy and Safety of Ainuovirine Treating With AIDS Patients Observational Guangzhou 8th People's Hospital
NCT01348516 Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023 Phase 1 Interventional Kainos Medicine Inc. 1